Some of them were composed of AML samples with known cytogenetic aberrations: t(18;21), t(15;17), and inv(16). RUNX1T1 gene, which is a RUNX1 fusion partner, was the most discriminative gene for AML with t(8;21). This evidence concerns the gene RUNX1T1 and acute myeloid leukemia.